Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Axial Spondyloarthritis
NCT01029847Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2009
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in axial spondyloarthritis (axSpA), sponsored by Rigshospitalet. Started Dec 2009; status: completed.
02
Drugs
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT01029847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01029847.